$1.80
-0.01-0.55%
At close: -
$1.83
0.031.67%
After Hours: Dec 20, 7:55 PM EDT
Caribou Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Caribou Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.38 | $-0.46 | 17.4 % |
Jun 2024 | 2024-08-06 | $-0.42 | $-0.45 | 6.67 % |
Mar 2024 | 2024-05-07 | $-0.46 | $-0.40 | -15.0 % |
Dec 2023 | 2024-03-11 | $-0.39 | $-0.37 | -5.41 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $2.02M | $3.10M | -34.7 % |
Jun 2024 | 2024-08-06 | $3.46M | $3.04M | 14.0 % |
Mar 2024 | 2024-05-07 | $2.43M | $2.90M | -16.2 % |
Dec 2023 | 2024-03-11 | $3.56M | $4.61M | -22.8 % |
Caribou Biosciences (CRBU) is scheduled to report earnings on March 10, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-0.38, which beat the estimate of $-0.46.
The Actual Revenue was $2M, which missed the estimate of $3.1M.
Browse earnings estimates, EPS, and revenue on all stocks.